Direkt zum Inhalt

Meindl, Christine ; Hochadel, Matthias ; Frankenstein, Lutz ; Bruder, Oliver ; Pauschinger, Matthias ; Hambrecht, Rainer ; von Scheidt, Wolfgang ; Pfister, Otmar ; Hartmann, Andreas ; Maier, Lars S. ; Senges, Jochen ; Unsöld, Bernhard

The role of diabetes in cardiomyopathies of different etiologies—Characteristics and 1-year follow-up results of the EVITA-HF registry

Meindl, Christine , Hochadel, Matthias, Frankenstein, Lutz, Bruder, Oliver, Pauschinger, Matthias, Hambrecht, Rainer, von Scheidt, Wolfgang, Pfister, Otmar, Hartmann, Andreas, Maier, Lars S., Senges, Jochen und Unsöld, Bernhard (2020) The role of diabetes in cardiomyopathies of different etiologies—Characteristics and 1-year follow-up results of the EVITA-HF registry. PLOS ONE 15 (6), e0234260.

Veröffentlichungsdatum dieses Volltextes: 17 Dez 2020 14:27
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.44152


Zusammenfassung

Background Type 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardiomyopathy. In contrast to diabetes and IHD, limited data exist regarding patients with diabetes and dilated cardiomyopathy (DCM). Methods EVIdence ...

Background Type 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardiomyopathy. In contrast to diabetes and IHD, limited data exist regarding patients with diabetes and dilated cardiomyopathy (DCM). Methods EVIdence based TreAtment in Heart Failure (EVITA-HF) comprises web-based case report data on demography, diagnostic measures, adverse events and 1-year follow-up of patients hospitalized for chronic heart failure and an ejection fraction <= 40%. In the present study we focused on the results of patients with diabetes and heart failure. Results Between February 2009 and November 2015, 4101 patients with chronic heart failure were included in 16 tertiary care centers in Germany. The mortality in patients with diabetes and DCM (n = 323) was more than double (15.2%) than that of DCM patients without diabetes (6.5%, p<0.001, n = 885). In contrast the mortality rate of patients withIHDwas not influenced by the presence of diabetes (17.6% in patients withIHDand diabetes n = 945, vs. 14.7% in patients withIHDand no diabetes, n = 1236, p = 0.061). The results also remained stable after performing a multivariable analysis (unadjusted p-value for interaction = 0.002, adjusted p = 0.046). Conclusion The influence of diabetes on the mortality rate is only significant in patients with DCM not in patients with CAD. Therefore, the underlying mechanisms of this effect should be studied in greater detail to improve patient care and outcome.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftPLOS ONE
Verlag:PLOS
Ort der Veröffentlichung:SAN FRANCISCO
Band:15
Nummer des Zeitschriftenheftes oder des Kapitels:6
Seitenbereich:e0234260
Datum11 Juni 2020
InstitutionenMedizin > Lehrstuhl für Innere Medizin II
Identifikationsnummer
WertTyp
10.1371/journal.pone.0234260DOI
Stichwörter / KeywordsHEART-FAILURE PATIENTS; VENTRICULAR DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; EJECTION FRACTION; MELLITUS; OUTCOMES; DISEASE; EMPAGLIFLOZIN; ABNORMALITIES; LISINOPRIL;
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-441523
Dokumenten-ID44152

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben